A report on the experiences of 13 patients found that the drug had no benefit for some and that some who benefited said the ...

A study found that some long COVID patients who took Paxlovid saw improvement. But experts said the research isn't enough to ...

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...

A study indicates that longer Paxlovid treatments could improve long COVID symptoms in some patients, highlighting the need ...

A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating symptoms. Research shows extended Paxlovid treatment could help restore ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

An up-close look at how patients respond to the drug at different times and doses adds nuance to a recent finding that ...

Extended courses of Paxlovid may alleviate symptoms in some patients with long Covid, though its effectiveness varies widely.

The findings run counter to a clinical trial which found no benefit from Paxlovid in long COVID patients WEDNESDAY, Jan. 8, ...

A recent patient-led case series highlights the potential benefits of extended courses of Pfizer Inc's (NYSE:PFE) Paxlovid ...

A detailed examination of how patients respond to the drug at various times and doses provides greater context to a recent ...